Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.

Pokorney SD, Piccini JP, Stevens SR, Patel MR, Pieper KS, Halperin JL, Breithardt G, Singer DE, Hankey GJ, Hacke W, Becker RC, Berkowitz SD, Nessel CC, Mahaffey KW, Fox KA, Califf RM; ROCKET AF Steering Committee & Investigators.; ROCKET AF Steering Committee Investigators..

J Am Heart Assoc. 2016 Mar 8;5(3):e002197. doi: 10.1161/JAHA.115.002197.

2.

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.

Stempel DA, Raphiou IH, Kral KM, Yeakey AM, Emmett AH, Prazma CM, Buaron KS, Pascoe SJ; AUSTRI Investigators..

N Engl J Med. 2016 May 12;374(19):1822-30. doi: 10.1056/NEJMoa1511049. Epub 2016 Mar 6.

3.

Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.

Mancia G, Omboni S, Chazova I, Coca A, Girerd X, Haller H, Parati G, Pauletto P, Pupek-Musialik D, Svyshchenko Y; FELT Study Group..

J Hypertens. 2016 Jan;34(1):139-48. doi: 10.1097/HJH.0000000000000767.

PMID:
26630216
4.

Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes.

Fulcher G, Matthews DR, Perkovic V, de Zeeuw D, Mahaffey KW, Mathieu C, Woo V, Wysham C, Capuano G, Desai M, Shaw W, Vercruysse F, Meininger G, Neal B; CANVAS trial collaborative group..

Diabetes Obes Metab. 2016 Jan;18(1):82-91. doi: 10.1111/dom.12589. Epub 2015 Dec 8.

PMID:
26450639
5.

Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).

Halperin JL, Hankey GJ, Wojdyla DM, Piccini JP, Lokhnygina Y, Patel MR, Breithardt G, Singer DE, Becker RC, Hacke W, Paolini JF, Nessel CC, Mahaffey KW, Califf RM, Fox KA; ROCKET AF Steering Committee and Investigators..

Circulation. 2014 Jul 8;130(2):138-46. doi: 10.1161/CIRCULATIONAHA.113.005008. Epub 2014 Jun 3.

6.

Tiotropium Respimat inhaler and the risk of death in COPD.

Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P; TIOSPIR Investigators..

N Engl J Med. 2013 Oct 17;369(16):1491-501. doi: 10.1056/NEJMoa1303342. Epub 2013 Aug 30.

7.

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.

Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A, Diener HC, Donnan GA, Halperin JL, Mahaffey KW, Mas JL, Massaro A, Norrving B, Nessel CC, Paolini JF, Roine RO, Singer DE, Wong L, Califf RM, Fox KA, Hacke W; ROCKET AF Steering Committee Investigators..

Lancet Neurol. 2012 Apr;11(4):315-22. doi: 10.1016/S1474-4422(12)70042-X. Epub 2012 Mar 7.

PMID:
22402056
8.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM; ROCKET AF Investigators..

N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.

9.

Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MP, Beeh KM, Rabe KF, Fabbri LM; POET-COPD Investigators..

N Engl J Med. 2011 Mar 24;364(12):1093-1103. doi: 10.1056/NEJMoa1008378.

10.

[The influence of antihypertensive agents on plasmatic and vascular-thrombocytic homeostasis in metabolic syndrome].

Vengerovskiĭ AI, Idrisova EM, Bushkova EA, Mananko EI, Krasnova NM.

Eksp Klin Farmakol. 2008 Nov-Dec;71(6):8-12. Russian.

PMID:
19140507
11.

[The efficiency of combinations of Enalapril and long-acting Nifedipin and Moxonidine in patients with arterial hypertension and a metabolic syndrome].

Mananko EI, Vorob'eva EV, Kalashnikova TP, Bushkova EA, Krasnova NM, Idrisova EM, Vengerovskiĭ AI, Karpov RS, Gruzdeva OV, Kremenko SV.

Klin Med (Mosk). 2008;86(7):56-61. Russian.

PMID:
18756750
12.

[Propranolol treatment of effort angina in patients with arterial hypotension].

Idrisova EM, Boshchenko AA, Borovkova NV, Demochko AV, Chernov VI, Karpov RS.

Ter Arkh. 2004;76(8):32-6. Russian.

PMID:
15471393
13.

[Diltiazem and verapamil therapy in patients with angina pectoris associated with arterial hypotension].

Idrisova EM, Stepacheva TA, Borovkova NV, Chernov VI, Karpov RS, Vorob'eva EV, Poponina IuS.

Klin Med (Mosk). 2004;82(2):42-6. Russian.

PMID:
15106511
14.

[Nitrates in therapy of effort angina in hypotensive patients].

Idrisova EM, Borovkova NV, Kladieva EA, Chernov VI, Demochko AV, Shishkina AA, Vorob'eva EV, Karpov RS.

Klin Med (Mosk). 2003;81(11):54-8. Russian.

PMID:
14689713
15.

[Long-acting isosorbide dinitrate and molsidomin in the treatment of effort angina in patients with arterial hypotension].

Idrisova EM, Kladieva EA, Borovkova NV, Vorob'eva EV, Chernov VI, Karpov RS.

Ter Arkh. 2002;74(6):63-6. Russian.

PMID:
12136489
16.

[The comparison of the efficacy of atenolol and isosorbide dinitrate therapy in chronic hypotension patients with stable angina pectoris].

Idrisova EM, Borovkova NV, Stepacheva TA, Chernov VI, Karpov RS.

Klin Med (Mosk). 2001;79(1):37-40. Russian.

PMID:
11234265
17.

[Effect of nifedipine (corinfar) on cerebrovascular circulation in patients with exertion-induced stenocardia].

Karpov RS, Idrisova EM, Dudko VA.

Kardiologiia. 1989 Mar;29(3):17-21. Russian.

PMID:
2659875
18.

[Late complications of VVI electric stimulation in patients with sick sinus syndrome].

Akhmedov ShD, Gimrikh EO, Volkova TG, Idrisova EM, Pekarskiĭ VV.

Kardiologiia. 1988 Feb;28(2):28-31. Russian.

PMID:
3373947

Supplemental Content

Loading ...
Support Center